Body Mind & Soul Spa | |
31 S Beretania St, Honolulu, HI 96813-2220 | |
(808) 524-8588 | |
Not Available |
Full Name | Body Mind & Soul Spa |
---|---|
Type | Facility |
Speciality | Massage Therapist |
Location | 31 S Beretania St, Honolulu, Hawaii |
Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1710363155 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
111N00000X | Chiropractor | DC-622 (Hawaii) | Secondary |
207R00000X | Internal Medicine | MD-7549 (Hawaii) | Secondary |
225700000X | Massage Therapist | MAT-9888 (Hawaii) | Primary |
Mailing Address | Practice Location Address |
---|---|
Body Mind & Soul Spa 31 S Beretania St, Honolulu, HI 96813-2220 Ph: (808) 524-8588 | Body Mind & Soul Spa 31 S Beretania St, Honolulu, HI 96813-2220 Ph: (808) 524-8588 |
News Archive
The Obama Administration's PEPFAR "Blueprint for an AIDS Free World" released yesterday by U.S. Secretary of State Hilary Clinton is an impressive and welcome roadmap forward," said Chris Norwood, Executive Director of Health People, Inc. in the South Bronx, where 2% of the adult population has HIV/AIDS.
Imagine a scenario where doctors from different hospitals can collaborate on a surgery without having to actually be in the operating room.
Tumor sequencing of several different lung cancers and their surrounding tissue complicates the prevailing theory of linear lung cancer progression and offers new insights for management of this deadly cancer, according to a new Mayo Clinic study.
Both spouses and first-degree relatives of patients with celiac disease are at increased risk of nonceliac autoimmune disease, according to a study in the July issue of Clinical Gastroenterology and Hepatology, the official clinical practice journal of the American Gastroenterological Association. This risk represents a mixture of genetic, environmental and ascertainment bias mechanisms.
An analysis of the phase III NRG Oncology clinical trial RTOG 9601 on men receiving salvage radiotherapy (SRT) following prostatectomy for recurrent prostate cancer indicated that, while biochemical failure (BF) was not a strong surrogate endpoint to determine overall survival (OS), metastasis-free survival (MFS) was in this patient population.
› Verified 6 days ago